Health & BiotechREGENXBIO's Duchenne Gene Therapy Targets 2027 Global Launch, Challenging Sarepta's Market LeadViaNews Editorial Team•Feb 18, 2026
MarketMarathon And Phunware On The List Of Winners And Losers Of Thursday's US SessionViaNews Editorial Team•Feb 8, 2024